Patricia Van Arnum's Blog

The Small- and Large-Molecule Divide in the Global Oncology Market

By Patricia Van Arnum posted 06-03-2014
0 comments

Finding the Niche in Orphan Drugs

By Patricia Van Arnum posted 04-29-2014
0 comments

Pfizer and AstraZeneca: What Would a Combined Company Offer?

By Patricia Van Arnum posted 04-29-2014
0 comments

IMS Report Shows Recovery in US Pharmaceutical Market

By Patricia Van Arnum posted 04-22-2014
1 comment

Manufacturing Issues Playing an Important Role in Biosimilar Strategies

By Patricia Van Arnum posted 04-22-2014
0 comments

Benchmarking US Biopharmaceutical R&D and Manufacturing Activity

By Patricia Van Arnum posted 04-15-2014
0 comments

FDA Begins Implementation Efforts for Drug Supply Chain Security Act

By Patricia Van Arnum posted 04-14-2014
0 comments

Contract Service Providers Expand

By Patricia Van Arnum posted 04-08-2014
0 comments

Global Biotech Financing Up in First Quarter

By Patricia Van Arnum posted 04-08-2014
0 comments